#68 A Leftist Primer on the Right-Wing Psychedelic Takeover
Release Date: 04/20/2026
#75 "Psychedelic Zealots" w/ Dr. Tyler Black
The Psymposia Podcast
Psymposia sits down with Dr. Tyler Black to discuss debunking pseudoscience, a recent case study involving giving a woman with Alzheimer's psilocybin, psychedelic zealot mindsets, and his ketamine research.
info_outline
#74.5 The Fight Over Trans Healthcare Under Trump w/ Jane Migliara Brigham
The Psymposia Podcast
This is an excerpted interview from episode #74. Psymposia speaks with Jane Migliara Brigham of The Needle to discuss her recent article, "Ambetter Insurance, Centene denying hormones to trans patients across 19 states in push for MAHA Medicine."
info_outline
#74 Psychedelic Billionaire Dystopia, Terence McKenna Archives, Trans Healthcare Under Trump 6.18.2026
The Psymposia Podcast
James, Russell, and Normie chat about the Best in Grass competition before diving into a discussion of a lawsuit against OpenAI over alleged bad drug advice and the preservation of the Terence McKenna archive. Russell conducts an in-depth interview with Jane Migliara Brigham on the state of trans healthcare under Trump, unpacking the policy landscape and its real-world implications. In the back half of the episode, the crew is joined by Mike and Neşe to discuss billionaire investor Christian Angermayer — breaking down his psychedelic origin story, his concept of “Societal Adjustment...
info_outline
#73 Enhanced Games Peptide Grift, MAHA Public Health Slop, Psychedelic Christian Nationalism 06.03.2026
The Psymposia Podcast
SUPPORT: FOLLOW: Normie, Neşe, Russell, and James dive into the telehealth supplement play behind the Enhanced Games, dissect the Secretary of Homeland Security's significant stake in Botanic Tonics, unpack the dangerous rhetoric of the MAHA movement and its real-world impact on mental health policy and infant mortality, and examine the key figure pushing ibogaine from fringe psychedelic to centerpiece of a broader Christian nationalist movement. Footnotes: The Enhanced Games Explained: Inside the $1.2 Billion Bet on Doping in Sports (Huddle Up) How a kratom giant got what it wanted from...
info_outline
Patreon Update: New Tiers and Offerings
The Psymposia Podcast
We have made some changes to our Patreon and wanted to let you know what to expect from your subscription moving forward! Simplified Tiers. We simplified our tiers so there will only be three offerings: a $5, $10, and $50 level The $2 tier is going away July 1, but any current $2 members will be grandfathered in at that price. Early Access. All of our paid members will receive early access to ad-free podcast episodes, generally released twice a month. Additionally, Patreon members will receive around 20-45 minutes of post-episode bonus content with each release! Group...
info_outline
#72 Patreon Exclusive: The Drug Culture of Looksmaxxing
The Psymposia Podcast
This clip from our Patreon bonus content breaks down the so-called “pentastack” behind looksmaxxer streams: a combinations of stimulants, dissociatives, performance drugs, and psychiatric medications. We also examine the disturbing response from the people around Clavicular during his livestreamed overdose.
info_outline
#71 Hamilton Morris Sued, MAGA Weirdo on Shrooms, VA Mental Health Collapse Under Trump 05.20.2026
The Psymposia Podcast
Russell, Normie, Pace and James debut a new podcast format covering the latest developments in psychedelics, drug policy, and politics. Today, they review the latest Church of Sacred Synthesis lawsuit news, misperceptions of the "psychedelic Left", Purdue Pharma’s collapse, the Trump administration's cuts to fentanyl test strip funding, vaccine and ivermectin discourse, and worsening conditions in veterans’ mental healthcare. Footnotes: Michelle Lhooq — “We Have Entered the Era of Conservative Psychedelia” Associated Press — “OxyContin maker Purdue Pharma to dissolve...
info_outline
#70 Telepathy in Psychedelic Therapy
The Psymposia Podcast
Psymposia board member Dr. Neşe Devenot’s presentation at the Ohio State University “Religion and Psychedelics” conference, recorded March 28, 2026. In this talk, Dr. Devenot presents their research on the reliance on unscientific telepathic attunement in many popular schools of psychedelic therapy.
info_outline
#69 Why is Professor Dave Promoting Psychedelic Grifters?
The Psymposia Podcast
Professor Dave is a well-known science communicator and prolific debunker of pseudoscience. Despite building his platform on combatting misinformation, he continues joining conversations that promote false claims about the FDA’s rejection of MDMA-assisted therapy — one of which he republished on his own channel. In this episode, Psymposia responds to the latest of these conversations on the Danny Jones Podcast. We encourage Professor Dave to do his homework on the psychedelic industry before aligning himself with the very pseudoscience promoters he's built his career opposing.
info_outline
#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover
The Psymposia Podcast
Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos’/Resilient's trials. Update to episode #68.
info_outlinePsychedelics are the next front in Big Tech's dystopia. Psymposia developed this primer for leftists in response to Donald Trump‘s April 18 Executive Order, which accelerates review of psychedelic drugs deemed “Breakthrough Therapies” and makes Schedule 1 drugs more accessible under Right to Try laws. This announcement made a splash in psychedelic media, where praise for the Trump administration mixes with false claims about an “end to prohibition.” In this discussion, we provide important context about this Executive Order and the people who engineered this moment behind the scenes. We highlight concerns about how this initiative will be rolled out by the Trump administration, which has been accused of pay-to-play tactics at the FDA and stacking the Department of Health and Human Services with psychedelic industry evangelists. This move represents a crystallization of far-right interest in the psychedelic industry and step towards oligarch monopolization of psychedelic medicine by figures including Peter Thiel and Musk lieutenant Antonio Gracias. We end by discussing the risks of elite control over drugs that have been developed to shift identity — especially when those elites are simultaneously devoted to killing the so-called "woke mind virus" and remaking the global order in Palantir's image.
Foot Notes:
Executive Order (White House): https://www.whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness/
President Trump Signs Executive Order to Accelerate Psychedelic Research and Access (Psychedelic Alpha): https://psychedelicalpha.com/news/president-trump-signs-executive-order-to-accelerate-psychedelic-research-and-access/
Over-the-top psychedelic promos could undermine the field’s drug development efforts (STAT): https://www.statnews.com/2026/03/31/psychedelic-biotech-promotion-scrutinized-helus-atai-influencer-marketing/
Archived: https://archive.is/bv1oU
Pharma lobbyists focus on a surprising new target: the FDA (STAT): https://www.statnews.com/2026/02/23/fda-lobbying-efforts-grow-under-trump-administration/ Archived: https://archive.is/wQav7
Wohin treibt die Renaissance von LSD & Co.? (WOZ)
https://www.woz.ch/2609/psychedelika/wohin-treibt-die-renaissance-von-lsd-co/!NBCC4R4K3E06